Clinical Trials Logo

Filter by:
  • Enrolling by invitation  
  • « Prev · Page [14]
NCT ID: NCT00708409 Enrolling by invitation - Clinical trials for Aortic Valve Disease

Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)

Start date: January 2001
Phase: N/A
Study type: Observational

With the current knowledge of aortic valve replacement modalities, no specific recommendations can be given and the decision for a particular prosthesis or procedure is rather arbitrarily. The investigators hypothesize that the autograft procedure according to Ross is superior in terms of hemodynamic (especially regression of left ventricular hypertrophy) and major adverse valve related events even in a long-term course

NCT ID: NCT00639652 Enrolling by invitation - Clinical trials for Carcinoma, Basal Cell

Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970

Start date: December 2007
Phase: N/A
Study type: Observational

Currently, we conduct a prospective, randomized trial comparing the outcome of surgical excision with the outcome of curettage in nodular and superficial BCCs. Larger BCCs and micronodular or sclerosing BCCs are not included in the randomized study. They are mainly operated using three-dimensional histology (3D-histology, micrographic surgery). In this observational study we measure the cosmetic result and the recurrence rate of all BCCs not included in the randomized trial.

NCT ID: NCT00420121 Enrolling by invitation - Clinical trials for Lupus Erythematosus, Systemic

European Society of Cutaneous Lupus Erythematosus (EUSCLE)

Start date: January 2007
Phase: N/A
Study type: Observational

Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical manifestations and a variable prognosis. The aim of the study is to create a standardized evaluation of the different subtypes of this disease in order to receive an overview of the spectrum of clinical and laboratory features as well as the therapeutic strategies for patients with CLE.